Using a randomized, retrospective case control survey approach, this study compared emplyees immunized (cases) to a group of non immunized employees (controls) between the months of October and December 1994. In May 1995, a self administered questionnaire was distributed to employees working at the Hanford nuclear reservation located in eastern Washington State. Bivariate analysis included chi-square tests to study the association between influenza vaccine and rates of influenza like illness and related complications, rates of employee absenteeism, rates of physician visits, use of prescribed medication, and rates of hospitalization. To assess the economic benefits associated with vaccination, analysis included estimating the direct and indirect costs associated with immunization and influenza like illnesses, and complications related to influenza like illnesses.
ees in the vaccinated group and 931 employees in the nonvaccinated group. As compared to vaccinated employees, nonvaccinated employees reported significantly higher rates of episodes of influenza like illness (78 per 100 compared to 59 per 100, p < 0), influenza related complications (8.0 compared to 5.0,p < .01), lost work days (63 per 100 compared to 35 per 100, p < 0), use of prescription medication (18.6 per 100 compared to 8.7 per 100, p < 0), physician visits (18.6 per 100 compared to 8.7 per 100, p < 0), and inpatient hospital. Cost savings were estimated to be $83.84 per person vaccinated.
The results of this study suggest this worksite influenza vaccination program produced significant health related and economic benefit to employee participants and their employers. A lthough preventable, influenza and influenza related complications rank as the sixth leading cause of death in the United States, with a reported 10,000 to 40,000 deaths occurring each year (Immunization Practices Advisory Committee, 1992) . In any given year, as much as 20% of the population may have an influenza like illness, with 25 million Americans affected (Immunization Practices Advisory Committee, 1993) . Influenza and its complications significantly affect hospitalization rates and, subsequently, health care spending. Estimates of annual costs associated with influenza during epidemic years exceed $12 billion (Barker, 1986) . Respiratory conditions (along with injuries) rank as the number one cause for lost work days per person due to acute conditions in the United States (Health Insurance Association of America, 1989) . A highly contagious disease, influenza strikes millions of people each year, keeping them home from work. During influenza outbreaks there is a significant rise in absenteeism in the worker population (Chapman, 1993) . Surveillance programs indicate that high absenteeism in the workplace is common during peak influenza activity, typically between December and March.
According to the Centers for Disease Control and Prevention (CDC), the influenza vaccine is approximately 70% effective in providing protection against the signs and symptoms of influenza, when the vaccine contains the circulating virus strains. Additionally, the vaccine reduces disease severity when it fails to protect from contracting influenza (Immunization Practices Advisory Committee, 1993) . The CDC strongly recommends developing special vaccination programs to target special groups of people at risk of influenza complications, including persons 65 years of age and older, residents of nursing homes and chronic care facilities, persons with chronic health disorders, their contacts, and health care workers. However, persons in the general population not considered at risk for complications are not targeted for special programs but encouraged to receive the vaccine if they wish to minimize disruption of routine activities (Immunization Practices Advisory Committee, 1994) .
While numerous studies have reported the effectiveness of the influenza vaccine among elderly persons in both institutional and community settings (Nichol, 1994) , studies focused on the positive benefits of influenza vaccination in the healthy, working adults have yielded conflicting reports (Smith, 1979; Weingarten, 1988) . Research about the cost effectiveness of worksite influenza vaccination programs may be of interest to employers who wish to reduce absenteeism and related costs.
This study was undertaken to measure and evaluate the outcomes of a comprehensive worksite influenza immunization program developed by a team of occupational health nurses working for the Hanford Environmental Foundation (HEHF), a private, non-profit corporation operating as a contractor to the Department of Energy, Richland (DOE-RL). In 1994 HEHF provided onsite occupational health services to the 20,000 DOE and contractor employees located at the Hanford nuclear reservation in southeastern Washington. Prior to the 1994-1995 influenza season, a team of occupational health nurses sought to increase influenza vaccination rates among contractor employees by developing a comprehensive vaccination program delivered to employees at multiple worksite locations. As a result of this planning, the program was successful in increasing influenza vaccination rates from the previous years' averages of 11% (1,800 employees vaccinated) to 35% (6,339 employees vaccinated). To increase accessibility and improve vaccination rates, immunizations were delivered to employees during a 4 week campaign, provided by occupational health nurses with standing orders, during working hours, and at numerous worksite locations on a drop in basis. The description of that program is included in this issue of the Journal (Hein-Dille, 1999: 47[7] , 292-300).
While this program was successful in increasing vaccination rates, the impact and effectiveness of the program in reducing the incidence of influenza like illness in the employee population had not been evaluated. The purpose of this study was to provide quantitative data to evaluate program effectiveness and ultimately to increase the number of employers and employees participating in worksite influenza immunization programs. The results of this study will help occupational health nurses in recommending, continuing, or expanding similar influenza vaccination programs at other workplace settings. At a time when industries are downsizing and looking for opportunities to cut overhead costs and prevention programs, this information may be useful to occupational health nurses to leverage an influenza immunization program and assist funding sources and program planners in making more informed decisions.
LITERATURE REVIEW
Influenza is caused by infection with influenza type A, B, or C viruses (Noble, 1982) . Influenza A viruses are subtyped into two surface antigens: hemagglutinin (H) and neuraminidase (N) antigens. Three types of the hemagglutinin antigen and two of the neuraminidase antigen cause widespread disease. These antigens frequently change over time, with minor changes within subtypes (Douglas, 1987) . Antigenic shifts occur when there is a major change in the subtypes resulting in a new strain to which there is little immunity and causing high attack rates across all age groups and world wide epidemics. Influenza A viruses cause moderate to severe illness and affect all age groups (Kendal, 1986) . Influenza B attacks rates are high for children but relatively lower for adults (Bean, 1983) . Influenza C rarely produces illness and does not produce epidemics (Betts, 1990) . Influenza illness is characterized by an acute febrile episode lasting from 3 to 5 days. The virus causes inflammation of the nasal mucosa, pharynx, conjunctiva, and respiratory tract. Symptoms vary with age, general health, and immune status (Immunization Practices Advisory Committee, 1991). In adults 20 to 49 years of age, symptoms predominately include dry (unproductive) cough, headache, myalgia, sore throat, including eye pain and sensitivity to light (CDC, 1992) . Complications associated with influenza include primary viral pneumonia, secondary bacterial pneumonia, bronchitis, exacerbation of chronic medical conditions, sinusitis, and otitis media (Glezen, 1986) . Influenza outbreaks and epidemics contribute significantly to the morbidity and mortality of population groups due to related symptoms and secondary infections such as pneumonia and bronchitis (Barker, 1986 (Barker, , 1980 .
Numerous studies provide support that influenza vaccination for the elderly is a cost effective method to reduce the incidence of influenza, reducing mortality rates and hospitalizations for pneumonia and influenza, respiratory conditions, and congestive heart failure (Strassburg, 1986; Russell, 1992; U.S. Department of Health and Human Services, 1993; Nichol, 1994) . However, past studies conducted during the 1950s and 1960s to assess the efficacy of influenza vaccination among the healthy population aged 18 to 64 years provided conflicting reports (Clinical Trials, 1957; Edmondson, 1971) . A study among postal workers in the United Kingdom suggested a positive benefit (Smith, 1979) . Another study conducted in 1985-1986 among hospital employees (Weingarten, 1988) failed to demonstrate benefits in reducing clinical illness and related lost work time, perhaps because of the small sample size and the poor match between the circulating viruses and the vaccine strains for that year.
Many studies have reported successful workplace strategies to increase vaccination rates among employees, including increasing accessibility (Freeman, 1987) , empowering nurses with standing orders (Crouse, 1992) , and modeling positive health behavior (Carter, 1992) . Prior to this study no studies were found that specifically measured the cost effectiveness of a worksite influenza immunization program delivered to healthy working adults in reducing the incidence of influenza like illness, related complications, lost work days, and related health care utilization.
RESEARCH QUESTIONS
This study was designed to answer the following questions:
• Was the worksite influenza program delivered to a specific employee population associated with reductions in the incidence rates of influenza and related upper respiratory illnesses, such as secondary infections and complications due to the virus, for the particular group vaccinated, compared with rates of those unvaccinated? • Was the program associated with a reduction in absenteeism in the vaccinated group versus the unvaccinated group? • Was the program associated with a reduction in related health care spending, with less utilization of health care resources and spending in the vaccinated group versus the unvaccinated?
METHODOLOGY

Participants
The study population included all Hanford employees eligible to receive the 1994-1995 influenza vaccine except individuals with sensitivity to thimersol, persons with a history of sensitivity to eggs, and pregnant women. The Hanford population was comprised of 60% male and 40% female employees. The mean category of age was 40-49 years. The largest category of worker was engineer/scientist 49%, followed by office/administration 33%, crafts/repair/service 10%, nuclear speclhazard waste worker 6%, and health care worker/fire/police 2%. Subjects to be surveyed were asked to participate on a voluntary basis to evaluate the effectiveness of HEHF's influenza vaccination program. The study was approved by HEHF's Medical Director as well as the Human Subjects Division of the University of Washington.
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Study Design
The basic study design incorporated a randomized, retrospective case control survey approach comparing vaccinated employees and non-vaccinated employees. Because employee occupational health records and HEHF epidemiological data did not capture absences of less than 5 consecutive work days nor respiratory illnesses specific to influenza, the study did not attempt to use this source of data (Epidemiologic Surveillance Data Center, 1992) .
Survey Instrument
The survey instrument consisted of a self administered questionnaire with 40 multiple choice questions. The questions were designed to obtain information related to: • Motivating factors for obtaining an influenza vaccine; • Factors that contributed to a decision not to obtain an influenza vaccine; • Existing chronic conditions; • Episodes of symptoms of an influenza like illness; and • Absenteeism, complications, and medical treatment that resulted from an episode of the influenza like illness.
Questions related to demographic information included the participant's age, gender, employer, work location, category of work, and hours of work. Prior to distribution the questionnaire was field tested for readability, clarity, language, level of information, and question format. To ensure anonymity, the survey instrument was unmarked and included no identifiers.
Data Collection
To determine an appropriate sample size of cases (employees vaccinated) and controls (employees non-vaccinated) a pilot study was conducted to estimate the percentage of employees ill with influenza like symptoms in the non-vaccinated population during the month of December 1994. This study instrument consisted of a one page questionnaire mailed in February 1995 to 200 employees selected from a computer generated random sampling. The pilot indicated that 18.18% of the non-vaccinated individuals had suspected influenza like symptoms consisting of a sudden onset of fever, muscle aches and pains, and headache or sore throat followed by extreme malaise. Epi Info 6.0 statistical software (Division of Surveillance and Epidemiology, Centers for Disease Control and Prevention, Atlanta, GA) was used to calculate the sample size for the larger survey, using the 18.18% estimated population ill, with an alpha of 0.05 and power of 80%. Because roughly 33% of all Hanford employees were vaccinated, a 2:1 control to case ratio was selected. An odds ratio of 1.5 was used for the calculation to attempt to detect a 50% difference in the vaccinated vs. non-vaccinated groups in the larger study. Initial calculations resulted in a sample size of 1,329. Because the pilot survey indicated a potential response rate of 54%, the number of employees to be surveyed was doubled to 2,658, and then increased by 8% to 2,880 to offset an anticipated major downsizing of the employee population.
Potential subjects were identified from a computer generated random sample that produced a mailing list and address labels. The labels were affixed to the outer mailing envelopes. No identifiers were placed on the questionnaires. In early May 1995, identical self administered questionnaires were mailed to individual employees randomly selected for both the control and case groups. The questionnaires were sent via plant mail to employees at their worksite stations. (Contractor management had given prior consent and support for employees to complete the questionnaire during working hours.) Both a cover letter and the survey instrument explained the purpose of the survey, gave instructions about how to mark the answers, and directed employees to return the survey in an enclosed envelope via plant mail. To maintain anonymity, employees were instructed to not identify themselves.
Data Analysis
Data collected on the survey instrument were entered into Microsoft Access (Microsoft, Redmond, WA), a computerized database software. Data analysis was performed using SSPS 6.1 for Windows statistical software (SSPS, Inc., Chicago, IL). Analysis began with a descriptive study of the population surveyed. Bivariate analysis included chi-square tests to study the association between the major independent variable (influenza vaccine) and the dependent variables (rates of influenza like illness; complications of influenza like illness such as bronchitis, otitis media, sinus infection, and pneumonia; rates of employee absenteeism due to influenza like illness and other related illnesses; health care utilization such as rate of physician visits, use of prescribed and over the counter medications, and hospitalizations).
Influenza like illness was defined as an episode of illness that included all these symptoms-sudden onset of fever, muscle aches and pains, and dry cough followed by extreme malaise-but not confirmed with laboratory tests.
To assess health related benefits associated with vaccination, vaccine effectiveness was calculated as the difference in the rates of outcome variables divided by the rate in the control group, multiplied by 100. To assess the economic benefits of vaccination the following calculations were used: Net Costs = Direct Costs + Indirect Costs Direct costs = costs of vaccination -estimated costs of medical care, potential disease prevented Indirect costs = costs of work time lost for vaccination -costs of potential work loss averted
The total direct and indirect costs for providing the 1994-1995 Worksite Influenza Immunization Program was $9.74 per vaccinated employee. The time needed away from work to obtain the vaccine was estimated at 30 minutes per employee, based on HEHF time studies conducted at each clinic site. Work loss costs were estimated at $175.24 per 8 hour day based on the 1994-1995 304 average monthly salary ($3,537.50) of full time Hanford employees (U.S. Department of Energy-Hanford, Human Resource Data PY 1994 . The costs for health care were obtained from the Group Health Northwest Claims Data for 1994-1995, and reflected costs specific to the local area medical providers, hospitals, and pharmacies. One primary care visit to a physician's office was estimated at $53.56 based on the mean fee for a visit to a physician's office for an established client. Costs for an average inpatient hospital stay for treatment of bronchitis or bacterial/viral pneumonia was estimated at $1,704 per day, based on the Washington State Department of Health, Health Care Users Guide for Central Washington, Charges by Illness Category, 1994-1995. Costs for antibiotic therapy were based on the use of a prescribed medication for the treatment of an upper respiratory infection, estimated at $45 per a 7 to 10 day course of therapy.
RESULTS
Characteristics of study subjects by vaccine status are shown in Table 1 . Of the 1,920 questionnaires mailed to non-vaccinated employees, a total of 931 surveys were returned (49% response rate). Of the 960 questionnaires mailed to vaccinated employees, a total of 789 surveys were returned (82% response rate). Randomization resulted in similar distribution for both vaccinated (cases) and unvaccinated (controls) for all baseline measures, i.e., gender, age, employer, category of work, hours worked, work locations, and chronic illness.
Health related benefits associated with influenza vaccination are shown in Table 2 . Episodes of an influenza like illness, characterized by a sudden onset of fever accompanied with sore throat, dry cough, and muscle pain followed by malaise, were reported at a higher rate in the unvaccinated employees (78 per 100) as compared to vaccinated employees (59 per 100, p0
). The total number of lost work days attributed to an influenza like illness was reported at higher rate among the unvaccinated (63 per 100) as compared to the vaccinated (35 per 100), p~O. A visit to a physician for treatment of symptoms of an influenza like illness and/or related complications was reported at a higher rate among the unvaccinated (18.6 per 100) as compared to the vaccinated (8.7 per 100), p~O. The use of prescription medication was also reported at a higher rate in the unvaccinated (18.6 per 100) as compared to the vaccinated (8.7 per 100), p~O. The rate of a first visit to a physician and the rate of use of a prescribed medication were directly correlated. Episodes of an inpatient hospitalization related to influenza like illness, or complications from that illness, were reported at a higher rate in the unvaccinated group (0.8 per 100) as compared to the vaccinated group (0.1 per 100), p~O. Total number of inpatient hospital days were reported at a higher rate in the unvaccinated (2.7 per 100) as compared to the vaccinated (0.2 per 100), p~O. Pneumonia was reported by both the vaccinated and unvaccinated as the primary diagnosis for hospitalization due to a Immunization Program was estimated to be $531,462 (6,339 employees vaccinated) .
STUDY LIMITATIONS
The predominant limitation of this study was related to the nature of its desig n. Because the survey instrument consisted of a self admi nistered questionnaire, reliability and validity may be an issue due to the varied ability of employees to read and comprehend the questio ns asked . Respondent bias in the self assessment of disease status and interpretation of influenza symptoms and outcomes may have resulted in skewed data due to the subjects' understanding and knowledge abo ut the disease and assoc iated outcomes. Recall bias may have threatened the accuracy of information. Because the questionnaire was mailed to participants at the end of the influenza season, the ability of participants to accurately recall the informa tion asked may have been compromised due to the length of time between actua l disease and survey (2 to 6 months). Subject attrition also posed a threat to study validity. Downsizing at Hanford during the 1994-1995 fiscal year resulted in the loss of 2,500 employees (12.5% of the population). This downsizing took place during the months just prior to the survey distribution, with potential loss of older employees more susceptible to the influenza virus. However, human resource data indicate the distribution of employees who were laid off were representative of the work force as a whole, with respect to age, gender, and category of work.
Because the questionnaire was totally anonymous and lacking identifiers, the information obtained could not be validated. However, the rationale for using an anonymous survey was to decrease employees' perception of risk for potential reprisals from management, increase honest responses, and increase response rate.
Finally, the incidence and prevalence of influenza virus in the employee's general community may have affected study outcomes. During the study year, there was a concurrent proliferation of outreach immunization campaigns in the community. The local health JULY 1999, VOL. 47, NO.7 department reported vaccinating a total of 9,000 individuals against influenza. Additionally, local pharmacies provided influenza immunizations as did the three local senior centers and several immediate physician care centers. These efforts may have resulted in lowering the exposure risk to the virus in the community. However, the large size of the Hanford employee population (n=20,000) and study group (n= 1,720) may have negated these effects, especially as both the case and control groups were as likely to be afflicted.
Validity of study results may be supported by the fact that the baseline differences in the vaccinated and unvaccinated employees were similar and the sample size adequate. Additionally, the study year (1994-1995 influenza season) was characterized by a similar match between the strains in the vaccine and the predominant circulating virus strains (Immunizations Practices Advisory Committee, 1995). The estimated benefits, though encouraging, may be even greater in years when influenza activity is higher, and when there are epidemics.
DISCUSSION
This study at Hanford was useful in evaluating the outcome of HEHF's 1994-1995 Influenza Immunization Program. The results strongly suggest that immunizing healthy adult employees against the current strain of influenza can be cost effective in reducing the rates of influenza like illness and complications secondary to influenza like illness, reducing related lost work time, and reducing health care utilization. The results from this study were useful in determining if the annual influenza vaccination program should be expanded, maintained, or reduced in size and scope. At a time when the U.S. Department of Energy and its contractors were downsizing and looking for opportunities to cut overhead costs, this information was useful to leverage the program and assist funding sources and program planners in making more informed decisions. The results of this study provide support to the assumption that worksite immunization programs are effective in reducing absenteeism. Future studies may wish to consider a method to include identification of employees studied to provide capability for follow up and verification of findings.
A study measuring the outcomes of influenza immunization on working adults in the Minneapolis area was also conducted during the same influenza season and reported similar findings (Nichol, 1995) . This study suggested that Fall influenza vaccination significantly reduced episodes of upper respiratory illnesses, reduced sick leave for upper respiratory illness, and resulted in cost savings. It is interesting to compare and contrast the similarities and differences between the Minneapolis and Hanford studies. Both studies were conducted during the 1994-1995 influenza season. Study subjects included healthy working adults between the ages of 18 and 64 years. Both studies evaluated the outcomes of influenza vaccination by comparing results in cohorts of vaccinated and unvaccinated workers, and the studies relied on self reported data. The Minneapolis study relied on subjects reporting illnesses as they occurred and, therefore, may have had more reliable data than the Hanford study. The study at Hanford relied on participant recall of information pertaining to illnesses, 2 to 6 months after the episodes of illnesses occurred. Differences in the two studies included sample size and definitions of outcome variables. The Hanford study included more subjects 0,726) as compared to the Minneapolis study (849).
The outcome variable related to illness in the Hanford study was described as an episode of influenza like illness that included all of the following symptoms: sudden onset of fever accompanied by sore throat, dry cough, and muscle aches followed by malaise. In the Minneapolis study the outcome variable, respiratory illness, was defined as a sore throat accompanied by a fever or cough. Reported findings related to health outcomes were remarkably similar in both studies. The Minneapolis study reported 25% fewer episodes of respiratory illness in the vaccinated group as compared to the unvaccinated, while the Hanford study found 24% fewer episodes of influenza like illness in the cohort of vaccinated employees versus unvaccinated. Vaccinated 308 employees in both studies reported fewer sick leave days associated with upper respiratory illness (Minneapolis, 43%) or an episode of influenza like illness (Hanford, 45%), as compared to their cohorts of unvaccinated employees.
Costs savings were also remarkably similar in both studies. The Minneapolis study reported potential net cost savings related to fewer sick leave days attributed to respiratory illness estimated at $47 for every person vaccinated. The Hanford study estimated potential net cost savings for lost work days avoided attributed to influenza like illness to be $38 per person vaccinated. The study at Hanford also considered direct savings in potential health care costs avoided, which were estimated at $45 per person vaccinated. Total combined potential cost savings in the Hanford study were estimated to be $83.84 per person vaccinated.
CONCLUSION
Both the Hanford and Minneapolis studies provide growing evidence to suggest that immunizing healthy adult workers against the current strain of influenza can reduce influenza like illness, related lost work time, and provide cost benefits to both employers and employees. The CDC and other public health agencies may want to consider placing more emphasis on influenza vaccination for the general public, as well as influence industry to support worksite influenza vaccine programs for their employees. Occupational nurses in other workplace settings may use this information to support the initiation or expansion of influenza vaccination programs for their employees.
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